OppenheimerFunds Inc. grew its holdings in shares of LHC Group, Inc. (NASDAQ:LHCG) by 10.4% in the 4th quarter, Holdings Channel reports. The fund owned 11,388 shares of the health services provider’s stock after purchasing an additional 1,071 shares during the period. OppenheimerFunds Inc.’s holdings in LHC Group were worth $698,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the company. American International Group Inc. raised its stake in shares of LHC Group by 7.2% during the third quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock valued at $889,000 after acquiring an additional 840 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of LHC Group by 28.0% during the fourth quarter. Crossmark Global Holdings Inc. now owns 5,036 shares of the health services provider’s stock valued at $308,000 after acquiring an additional 1,103 shares during the last quarter. Comerica Bank raised its stake in shares of LHC Group by 9.1% during the third quarter. Comerica Bank now owns 17,125 shares of the health services provider’s stock valued at $1,145,000 after acquiring an additional 1,426 shares during the last quarter. Rhumbline Advisers raised its stake in shares of LHC Group by 5.1% during the third quarter. Rhumbline Advisers now owns 32,650 shares of the health services provider’s stock valued at $2,316,000 after acquiring an additional 1,592 shares during the last quarter. Finally, LS Investment Advisors LLC raised its stake in shares of LHC Group by 249.5% during the fourth quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock valued at $152,000 after acquiring an additional 1,769 shares during the last quarter. 89.76% of the stock is owned by hedge funds and other institutional investors.
In related news, COO Donald Dwayne Stelly sold 14,216 shares of LHC Group stock in a transaction on Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total transaction of $909,824.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 14.80% of the stock is owned by company insiders.
LHC Group, Inc. (NASDAQ:LHCG) opened at $63.07 on Tuesday. LHC Group, Inc. has a 52 week low of $49.56 and a 52 week high of $76.14. The firm has a market cap of $1,162.76, a price-to-earnings ratio of 22.61, a P/E/G ratio of 1.49 and a beta of 0.68. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 1.97.
LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, February 28th. The health services provider reported $0.62 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.62. LHC Group had a net margin of 4.67% and a return on equity of 9.18%. The business had revenue of $292.40 million during the quarter, compared to the consensus estimate of $280.82 million. During the same quarter last year, the firm earned $0.58 earnings per share. LHC Group’s quarterly revenue was up 24.2% on a year-over-year basis. analysts expect that LHC Group, Inc. will post 3.03 EPS for the current fiscal year.
Several equities analysts have recently issued reports on the stock. BidaskClub downgraded shares of LHC Group from a “sell” rating to a “strong sell” rating in a research note on Thursday, December 7th. Zacks Investment Research raised shares of LHC Group from a “sell” rating to a “hold” rating in a research note on Wednesday, January 31st. Oppenheimer reaffirmed a “buy” rating and set a $85.00 price target on shares of LHC Group in a research note on Thursday, December 7th. Robert W. Baird set a $71.00 price target on shares of LHC Group and gave the company a “hold” rating in a research note on Tuesday, November 28th. Finally, William Blair reissued an “outperform” rating on shares of LHC Group in a research note on Tuesday, November 21st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $76.70.
COPYRIGHT VIOLATION NOTICE: “OppenheimerFunds Inc. Has $698,000 Stake in LHC Group, Inc. (LHCG)” was published by Stock Observer and is the property of of Stock Observer. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thestockobserver.com/2018/03/20/oppenheimerfunds-inc-has-698000-stake-in-lhc-group-inc-lhcg.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.